NxThera Company Profile

07:05 EDT 19th March 2018 | BioPortfolio

NxThera develops medical technologies to treat a variety of endourology conditions, including BPH. The Company’s Rezūm System delivers vapor directly to the prostate to reduce the tissue volume that causes urinary obstruction in a simple, office-based procedure designed to take only minutes, with minimal discomfort, and resulting in rapid and significant improvements in urinary flow and patient quality of life. BPH afflicts more than 32 million men in the United States. For more information on NxThera, visit or call (651) 484-0219.

News Articles [3 Associated News Articles listed on BioPortfolio]

NxThera Announces Rezūm® Center of Excellence Program Recognizing Top Urologists for Expertise in BPH Treatment

The Rezūm Center of Excellence program recognizes distinguished urologists across the country for their outstanding care of men suffering from lower urinary tract symptoms caused by BPH, and their ac...

Pacific Urology Receives Recognition as Rezūm® Center of Excellence

Dr. Parminder Sethi and associates provide expertise in BPH treatment in the Bay Area. WALNUT CREEK, Calif. (PRWEB) March 06, 2018 Pacific Urology announced today that Dr. Parminder Sethi and his ass...

Florida Hospital Physician Group Urology Specialist First in Brandon to Offer New Minimally Invasive Treatment for Enlarged Prostate

Revolutionary technology offers an alternative to the side-effects of medication while providing results similar to surgery TAMPA, Fla. (PRWEB) January 18, 2018 Jared J. Wallen, MD, a Brandon, Florid...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Rezum FIM Optimization

Evaluate the effect of the NxThera BPH Rezum System on prostate tissue in subjects suffering from LUTS symptoms secondary to benign prostatic hyperplasia (BPH).

Companies [2 Associated Companies listed on BioPortfolio]


NxThera develops medical technologies to treat a variety of endourology conditions, including BPH. The Company’s Rezūm System delivers vapor directly to the prostate to re...

NxThera, Inc.

NxThera is pioneering the application of its sterile water vapor technology platform in a variety of endourology conditions including BPH, prostate cancer and kidney cancer. NxThe...

More Information about "NxThera" on BioPortfolio

We have published hundreds of NxThera news stories on BioPortfolio along with dozens of NxThera Clinical Trials and PubMed Articles about NxThera for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NxThera Companies in our database. You can also find out about relevant NxThera Drugs and Medications on this site too.

Quick Search


Relevant Topics

Benign Prostatic Hyperplasia (BPH)
An enlarged prostate (benign prostatic enlargement (BPE) or benign prostatic hyperplasia (BPH)) is common in men after the age of about 50. Having an enlarged prostate does not mean you have cancer. In some cases, an enlarged prostate can cause the ...

Benign Prostatic Hyperplasia (BPH) Erectile Dysfunction Urology Urology is the branch of medicine concerned with the urinary tract and diseases that affect it. Examples include urethritis, urethrostenosis and incontinence. Urology is a su...

Corporate Database Quicklinks

Searches Linking to this Company Record